Michael Yee
Stock Analyst at Jefferies
(2.73)
# 1,953
Out of 4,876 analysts
82
Total ratings
41.07%
Success rate
7.19%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BPMC Blueprint Medicines | Initiates: Buy | $135 | $128.15 | +5.35% | 1 | Mar 17, 2025 | |
| ALXO ALX Oncology Holdings | Upgrades: Buy | $2 → $3 | $0.45 | +562.84% | 5 | Mar 6, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Hold | $32 → $3 | $4.19 | -28.40% | 3 | Jan 30, 2025 | |
| KOD Kodiak Sciences | Upgrades: Buy | $20 | $3.78 | +429.10% | 3 | Dec 9, 2024 | |
| BIIB Biogen | Downgrades: Hold | $250 → $180 | $126.92 | +41.82% | 5 | Dec 9, 2024 | |
| VRTX Vertex Pharmaceuticals | Upgrades: Buy | $500 → $550 | $443.40 | +24.04% | 4 | Dec 9, 2024 | |
| AMGN Amgen | Maintains: Buy | $380 | $279.11 | +36.15% | 5 | Nov 12, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $40 → $45 | $14.50 | +210.45% | 2 | Nov 1, 2024 | |
| MRNA Moderna | Maintains: Hold | $65 → $55 | $27.54 | +99.71% | 8 | Oct 15, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $35 | $11.29 | +210.01% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $11.63 | +243.94% | 1 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $385 | $803.95 | -52.11% | 4 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1.4 → $10 | $1.97 | +407.61% | 3 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $3 | $3.19 | -5.96% | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $30 | $17.14 | +75.03% | 2 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $60 → $20 | $15.90 | +25.79% | 8 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 → $20 | $35.48 | -43.63% | 3 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $63 → $75 | $7.37 | +917.64% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $2.45 | +1,124.49% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $32.12 | +102.37% | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $1,875 → $1,125 | $5.30 | +21,126.42% | 2 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 → $30 | $1.02 | +2,841.18% | 4 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $30 | $6.18 | +385.44% | 3 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $120 | $17.17 | +599.10% | 2 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $70 → $75 | $20.49 | +266.03% | 2 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $14.79 | +102.84% | 1 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $77 | $13.11 | +487.34% | 2 | Nov 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $107.62 | - | 3 | Jan 26, 2018 |
Blueprint Medicines
Mar 17, 2025
Initiates: Buy
Price Target: $135
Current: $128.15
Upside: +5.35%
ALX Oncology Holdings
Mar 6, 2025
Upgrades: Buy
Price Target: $2 → $3
Current: $0.45
Upside: +562.84%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Hold
Price Target: $32 → $3
Current: $4.19
Upside: -28.40%
Kodiak Sciences
Dec 9, 2024
Upgrades: Buy
Price Target: $20
Current: $3.78
Upside: +429.10%
Biogen
Dec 9, 2024
Downgrades: Hold
Price Target: $250 → $180
Current: $126.92
Upside: +41.82%
Vertex Pharmaceuticals
Dec 9, 2024
Upgrades: Buy
Price Target: $500 → $550
Current: $443.40
Upside: +24.04%
Amgen
Nov 12, 2024
Maintains: Buy
Price Target: $380
Current: $279.11
Upside: +36.15%
Denali Therapeutics
Nov 1, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $14.50
Upside: +210.45%
Moderna
Oct 15, 2024
Maintains: Hold
Price Target: $65 → $55
Current: $27.54
Upside: +99.71%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $11.29
Upside: +210.01%
Sep 13, 2024
Initiates: Buy
Price Target: $40
Current: $11.63
Upside: +243.94%
Jul 17, 2024
Initiates: Buy
Price Target: $385
Current: $803.95
Upside: -52.11%
Mar 27, 2024
Upgrades: Buy
Price Target: $1.4 → $10
Current: $1.97
Upside: +407.61%
Mar 15, 2024
Downgrades: Hold
Price Target: $16 → $3
Current: $3.19
Upside: -5.96%
Dec 8, 2023
Downgrades: Hold
Price Target: $75 → $30
Current: $17.14
Upside: +75.03%
Oct 25, 2023
Downgrades: Hold
Price Target: $60 → $20
Current: $15.90
Upside: +25.79%
Oct 25, 2023
Upgrades: Buy
Price Target: $8 → $20
Current: $35.48
Upside: -43.63%
Jan 6, 2023
Upgrades: Buy
Price Target: $63 → $75
Current: $7.37
Upside: +917.64%
Nov 15, 2021
Initiates: Buy
Price Target: $30
Current: $2.45
Upside: +1,124.49%
Mar 2, 2021
Initiates: Buy
Price Target: $65
Current: $32.12
Upside: +102.37%
Mar 2, 2021
Downgrades: Hold
Price Target: $1,875 → $1,125
Current: $5.30
Upside: +21,126.42%
Feb 12, 2021
Downgrades: Hold
Price Target: $40 → $30
Current: $1.02
Upside: +2,841.18%
Feb 12, 2021
Upgrades: Buy
Price Target: $15 → $30
Current: $6.18
Upside: +385.44%
Nov 6, 2020
Downgrades: Hold
Price Target: $120
Current: $17.17
Upside: +599.10%
Oct 12, 2020
Upgrades: Buy
Price Target: $70 → $75
Current: $20.49
Upside: +266.03%
Sep 14, 2020
Initiates: Buy
Price Target: $30
Current: $14.79
Upside: +102.84%
Nov 8, 2018
Assumes: Buy
Price Target: $77
Current: $13.11
Upside: +487.34%
Jan 26, 2018
Upgrades: Buy
Price Target: n/a
Current: $107.62
Upside: -